These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17493581)

  • 1. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats.
    Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K
    Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems.
    Adrian JE; Poelstra K; Scherphof GL; Molema G; Meijer DK; Reker-Smit C; Morselt HW; Kamps JA
    J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
    Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
    Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K
    Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes.
    Adrian JE; Kamps JA; Poelstra K; Scherphof GL; Meijer DK; Kaneda Y
    J Drug Target; 2007 Jan; 15(1):75-82. PubMed ID: 17365276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-induced drug targeting using novel peptide-ligand albumins.
    Meijer DK; Beljaars L; Molema G; Poelstra K
    J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
    Hagens WI; Mattos A; Greupink R; de Jager-Krikken A; Reker-Smit C; van Loenen-Weemaes A; Gouw IA; Poelstra K; Beljaars L
    Pharm Res; 2007 Mar; 24(3):566-74. PubMed ID: 17245650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells.
    Zhang J; Zhang QS; Chen XM; Tian GY
    Glycoconj J; 2002 Jul; 19(6):423-9. PubMed ID: 14707489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells.
    Greupink R; Bakker HI; van Goor H; de Borst MH; Beljaars L; Poelstra K
    Pharm Res; 2006 Aug; 23(8):1827-34. PubMed ID: 16850269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers.
    Hagens WI; Beljaars L; Mann DA; Wright MC; Julien B; Lotersztajn S; Reker-Smit C; Poelstra K
    J Pharmacol Exp Ther; 2008 Mar; 324(3):902-10. PubMed ID: 18077624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
    van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
    J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.
    Kamps JA; Morselt HW; Swart PJ; Meijer DK; Scherphof GL
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11681-5. PubMed ID: 9326670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
    Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
    Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.
    Patel G; Kher G; Misra A
    J Drug Target; 2012 Feb; 20(2):155-65. PubMed ID: 21913877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor.
    Prakash J; Beljaars L; Harapanahalli AK; Zeinstra-Smith M; de Jager-Krikken A; Hessing M; Steen H; Poelstra K
    Int J Cancer; 2010 Apr; 126(8):1966-1981. PubMed ID: 19795464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor.
    Beljaars L; Molema G; Schuppan D; Geerts A; De Bleser PJ; Weert B; Meijer DK; Poelstra K
    J Biol Chem; 2000 Apr; 275(17):12743-51. PubMed ID: 10777570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.
    van Beuge MM; Prakash J; Lacombe M; Post E; Reker-Smit C; Beljaars L; Poelstra K
    Pharm Res; 2011 Aug; 28(8):2045-54. PubMed ID: 21442374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.